Does hyperthermic intraperitoneal chemotherapy influence the rate of infective complications and change the pattern of infectious agents in patients undergoing cytoreductive surgery for peritoneal carcinomatosis? . Ann Med Res [Internet]. 2021 May 25 [cited 2025 Apr. 4];28(3):0586-92. Available from: http://annalsmedres.org/index.php/aomr/article/view/417